ACADS
protein-codingacyl-CoA dehydrogenase short chain, the group of Acyl-CoA dehydrogenase family
Gene summary
This gene encodes a tetrameric mitochondrial flavoprotein, which is a member of the acyl-CoA dehydrogenase family. This enzyme catalyzes the initial step of the mitochondrial fatty acid beta-oxidation pathway. Mutations in this gene have been associated with short-chain acyl-CoA dehydrogenase (SCAD) deficiency. Alternative splicing results in two variants which encode different isoforms. [provided by RefSeq, Oct 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~14.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0008722
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0008722
Submitter: ClinGen
Inheritance Pattern: AR
Disease ID:MONDO:0008722
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0008722
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0008722
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0008722
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Biochemical;Musculoskeletal; Neurologic
Intervention: Biochemical
Rationale: Clinical manifestations range from infantile acute acidosis and muscle weakness to chronic adult myopathy, and in the infantile forms, medical/dietary therapy (eg, IV glucose/carnitine in the initial phase, and low-fat, diet with MCT oil and carnitine and riboflavin, as well as avoidance of fasting) can be effective
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ACADS variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000017.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 80 | 3 | 86 | ||
| missense | 5 | 50 | 160 | 6 | 221 | |
| nonsense | 6 | 6 | 1 | 13 | ||
| start loss | 1 | 2 | 3 | |||
| frameshift | 9 | 22 | 2 | 33 | ||
| splice donor/acceptor (+/-2bp) | 2 | 14 | 16 | |||
| Total | 23 | 94 | 166 | 86 | 3 | 372 |
Highest pathogenic variant AF is 0.0005020338
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000008.1 | 10 | MANE Select | |
| Ensembl | ENSP00000242592.4 | 10 | MANE Select | |
| RefSeq | NP_001289483.1 | 10 | Standard | |
| Ensembl | ENSP00000401045.2 | 10 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Butanoate metabolism - Homo sapiens (human)
- Fatty acid degradation - Homo sapiens (human)
- Valine, leucine and isoleucine degradation - Homo sapiens (human)
- Long chain acyl-CoA dehydrogenase deficiency (LCAD)
- 3-Methylglutaconic Aciduria Type I
Biological Process
- fatty acid beta-oxidation
- fatty acid beta-oxidation using acyl-CoA dehydrogenase
- butyrate catabolic process
Molecular Function
- acyl-CoA dehydrogenase activity
- butyryl-CoA dehydrogenase activity
- flavin adenine dinucleotide binding
Cellular Component
- nucleus
- nucleoplasm
- mitochondrion
- mitochondrial matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000242592
- Coding exons
- 10
- Length
- 14274
- Individuals with no LoFs
- 125708
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 40
- Defined
- 125748
- p
- 0.000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.584 | 239 | 266 | 0.899 | 0.0000182 | 2650 |
| Missense (PolyPhen) | 117 | 131.42 | 0.89029 | 1266 | ||
| Synonymous | 0.319 | 113 | 117 | 0.963 | 0.00000936 | 845 |
| Loss of Function | 1.74 | 12 | 20.5 | 0.586 | 9.92e-7 | 223 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00038 | 0.00037 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000055 | 0.000054 | rare |
| Finnish | 0.00023 | 0.00023 | rare |
| European (Non-Finnish) | 0.00014 | 0.00014 | rare |
| South Asian | 0.00026 | 0.00026 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Introduces a double bond at position 2 in saturated acyl-CoA's of short chain length, i.e. less than 6 carbon atoms. {ECO:0000250|UniProtKB:P15651}.;
- Disease
- DISEASE: Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470]: An inborn error of mitochondrial fatty acid beta- oxidation resulting in acute acidosis and muscle weakness in infants, and a form of lipid-storage myopathy in adults. {ECO:0000269|PubMed:11134486, ECO:0000269|PubMed:1692038, ECO:0000269|PubMed:9499414}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.526
Intolerance Scores
- LoFtool
- 0.196
- RVIS EVS
- -0.2
- RVIS percentile EVS
- 39.11
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.709
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |